Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1
- 31 March 1995
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 57 (1-2), 193-198
- https://doi.org/10.1016/0165-5728(95)00011-p
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's diseaseGlia, 1993
- Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.The Journal of Experimental Medicine, 1993
- Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.The Journal of Experimental Medicine, 1992
- Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.Journal of Clinical Investigation, 1992
- Modulation of the Immune Response by Transforming Growth Factor BetaInternational Archives of Allergy and Immunology, 1992
- Anti—tumor necrosis factor therapy abrogates autoimmune demyelinationAnnals of Neurology, 1991
- Human monocyte chemoattractant protein-1 (MCP-1)Immunology Today, 1990
- The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-λ, tumor necrosis factor α, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentationJournal of Neuroimmunology, 1989
- Astrocytes present myelin basic protein to encephalitogenic T-cell linesNature, 1984
- Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.The Journal of cell biology, 1980